Posted:
7/9/2025, 8:13:33 AM
Location(s):
Stockholm, Sweden
Experience Level(s):
Mid Level
Field(s):
Data & Analytics
At Pfizer we are a patient centric company, guided by our four values: courage, joy, equity and excellence. Our breakthrough culture lends itself to our dedication to transforming millions of lives.
We aim to create a trusting, flexible workplace culture which encourages employees to achieve work life harmony, attracts talent and enables everyone to be their best working self. Let’s start the conversation!
We are seeking a PhD student to analyze proteomics and other omics data to study the molecular effects of medication. The doctoral student will analyze data generated by advanced methods of human blood samples that originate from clinical trials and will contribute to the development of methods that broaden the scientific conclusions that can be drawn from such analysis by integration with public datasets. This role will involve development and application of bioinformatics pipelines for data analysis, integration of multiple layers of data, and developing interfaces for data interpretation and visualization.
ROLE SUMMARY
The PhD student will be part of The SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS), which aims to train the next-generation of data-driven life scientists and create globally leading computational and data science capabilities in Sweden.
The position is an Industrial PhD Project in Data-driven Life Science focusing on data-driven precision medicine and diagnostics.
The DDLS program is funded with a total of 3.1 billion SEK (about 290 MUSD) over 12 years from the Knut and Alice Wallenberg (KAW) Foundation. For more information, please see https://www.scilifelab.se/data-driven/ddls-research-school/.
This work will be supervised by Prof. Jochen Schwenk at KTH and members from Pfizer’s Biomarker Statistics group. The student will interact with an interdisciplinary team of research engineers, PhD students, postdocs, and researchers and work at Science for Life Laboratory, a national center for molecular biosciences with a focus on health and environmental research.
WHAT WE OFFER
CORE QUALIFICATIONS
To be admitted to postgraduate education (Chapter 7, 39 § Swedish Higher Education Ordinance), the applicant must have basic eligibility in accordance with either of the following:
ADDITIONAL QUALIFICATIONS
To succeed as a doctoral student at KTH, the candidate will need to be goal-oriented and persistent in their work. During the selection process, candidates will be assessed based on their ability to:
After the qualification requirements, emphasis will be placed on personal qualities and suitability.
Join us in making breakthroughs that change patients´ lives.
Please submit your application, with CV and cover letter in English, no later than July 31st. Selection process will start in August, and candidates should not expect updates during July.
We look forward to receiving your application.
Employment agreement: Pfizer AB on a local fixed term (PhD student) contract, maximum 4 years, full time.
Target degree: Doctoral degree
Equal Employment Opportunity
We believe that a diverse and inclusive workforce is crucial to building a successful business. As an employer, Pfizer is committed to celebrating this, in all its forms – allowing for us to be as diverse as the patients and communities we serve. Together, we continue to build a culture that encourages, supports and empowers our employees.
Disability Inclusion
Our mission is unleashing the power of all our people and we are proud to be a disability inclusive employer, ensuring equal employment opportunities for all candidates. We encourage you to put your best self forward with the knowledge and trust that we will make any reasonable adjustments to support your application and future career. Your journey with Pfizer starts here!
Research and Development#LI-PFEWebsite: https://www.pfizer.com/
Headquarter Location: New York, New York, United States
Employee Count: 10001+
Year Founded: 1849
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical ⋅ Precision Medicine